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Abstract
The purpose of this study was to combine a three-dimensional NMR-compatible bioreactor with
hyperpolarized 13C NMR spectroscopy in order to probe cellular metabolism in real time. JM1
(immortalized rat hepatoma) cells were cultured in a three-dimensional NMR-compatible fluidized
bioreactor. 31P spectra were acquired before and after each injection of hyperpolarized [1-13C]
pyruvate and subsequent 13C spectroscopy at 11.7 T. 1H and two-dimensional 1H-1H-total correlation
spectroscopy spectra were acquired from extracts of cells grown in uniformly labeled 13C-glucose,
on a 16.4 T, to determine 13C fractional enrichment and distribution of 13C label. JM1 cells were
found to have a high rate of aerobic glycolysis in both two-dimensional culture and in the bioreactor,
with 85% of the 13C label from uniformly labeled 13C-glucose being present as either lactate or
alanine after 23 h. Flux measurements of pyruvate through lactate dehydrogenase and alanine
aminotransferase in the bioreactor system were 12.18 ± 0.49 nmols/sec/108 cells and 2.39 ± 0.30
nmols/sec/108 cells, respectively, were reproducible in the same bioreactor, and were not
significantly different over the course of 2 days. Although this preliminary study involved
immortalized cells, this combination of technologies can be extended to the real-time metabolic
exploration of primary benign and cancerous cells and tissues prior to and after therapy.
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There is growing interest in the changes in fluxes through a variety of metabolic pathways
associated with the evolution and progression of cancer (1–7) and its response to therapy.
Recently, dynamic nuclear polarization (DNP) spectroscopic techniques have been used to
study these metabolic fluxes in real time (8,9). Focus has been placed on changes in pathways
associated with lipid synthesis and degradation (10,11), bioenergetics (12,13), and redox
potential (14,15). Increases in lactate dehydrogenase (LDH) activity (8,9), changes in
glutaminolysis (2), and decreases in pyruvate kinase activity (1) have been associated with
cancer. These studies have been conducted primarily in extracts of cell cultures (3) or by way
of in vivo animal studies (16–18). Cell culture studies provide a controlled platform for long-
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term metabolic studies, but they are tedious since each measurement requires new cells. In
contrast, in in vivo studies the same animal can be used for multiple metabolic measurements,
but they are more costly, are biologically heterogeneous, require many animals to be sacrificed,
and are inefficient for the initial screening of novel metabolic tracers.
For the last 3 decades, cell perfusion or “bioreactor” systems have been developed in an attempt
to address these fundamental issues (15,19,20). These three-dimensional culture perfusion
systems have allowed the monitoring of steady-state metabolites and their changes with time
(21,22), typically through the analysis of output parameters such as concentrations of lactate,
glucose, and alanine in media (23). Studies have also been performed in order to assess slow
metabolic processes, such as phospholipid (24), glutathione (25), and glutamine metabolism
(26), but these systems do not have the temporal resolution to study fast kinetic reactions.
Due to the dynamic nature of cellular metabolism and its instantaneous response to changing
stimuli (environmental, genetic, etc.) the study of flux through pathways, now dubbed
“fluxomics”, has become a rapidly expanding area of research in metabolomics (27,28). An
inherent problem associated with determining real-time fluxes is the speed of some metabolic
reactions. Enzymes of clinical interest, such as LDH, have been measured to have relatively
high velocities (29), and thus measurement of flux through LDH in a living system is difficult.
While glucose conversion to lactate by 13C NMR has been achieved, it has involved long
glucose infusion periods relative to the rates of the reactions in tissues of interest (30). A great
deal of work has been done determining steady-state metabolite concentrations and inferring
metabolic flux by mass spectrometry (31), NMR (32), and spectrophotometry (33). However,
these traditional methods require the system to be quenched and extracted for each time point
necessary to calculate flux. NMR spectroscopy is a research tool that can be readily translated
to the clinic. 13C NMR spectroscopy provides high spectral resolution and has been used to
study metabolic fluxes in a variety of systems (34). The major shortcoming of 13C NMR
spectroscopy is its lack of sensitivity due to a low gyromagnetic ratio (γ), resulting in the
inability to measure flux with high spatial and temporal resolution. This major hindrance has
been recently overcome through the development of DNP NMR spectroscopy (35). 13C-labeled
substrates have been recently polarized using DNP techniques to obtain tens-of-thousands-fold
enhancement of 13C NMR signals of the substrate and its metabolic products, enabling
measurement of rapid metabolic fluxes such as those catalyzed by LDH and alanine
aminotransaminase (ALT).
Recent studies of hyperpolarized 13C-labeled compounds, by way of the DNP method (8,9,
36), have been used to investigate metabolic processes associated with increases in aerobic
glycolysis, deemed the Warburg effect (36,37). The Warburg intermediates (elevated lactate,
alanine, and pyruvate) have been used as a way to characterize cancer aggressiveness (8) and
response to therapy (9). In this study, JM1 (immortalized rat hepatoma) cells were cultured in
a three-dimensional NMR-compatible bioreactor (38), and injections of hyperpolarized
[1-13C] pyruvate were used to serially measure LDH and ALT fluxes in real time.
MATERIALS AND METHODS
Cell Culture and Bioreactor
JM1 rat hepatoma cells (Michalopoulos Lab, University of Pittsburgh, PA) were cultured in
Dulbecco’s modified Eagle’s medium (Invitrogen; 3 g/L glucose) supplemented with 10% fetal
calf serum, 100 units/mL penicillin, and 100 μg/mL streptomycin (Invitrogen, Carlsbad, CA).
Cells were grown in T150-flasks (Fisher Scientific, Pittsburgh, PA) to incubated at 37°C in a
95% air/5% CO2 incubator. For two-dimensional (2D) culture extract experiments, cells were
plated on 150-cm2 coated plates (Fisher Scientific) and grown to less than 90% confluency
(12.6 × 106 cells). Medium was changed for each plate and replaced with analogous medium
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supplemented with uniformly labeled 13C-glucose (Cambridge Isotope Labs, Andover, MA).
Plates were allowed to progress for 23 h (n = 4). At each time point, an aliquot of medium was
collected, and plates were washed twice with ice-cold phosphate-buffered saline and extracted
in ice-cold methanol as previously described (39). Residual pellets were also extracted in
deuterated chloroform to assess the labeling of lipids (40). Fractional enrichment (FE) was
defined as the percentage of 13C-labeled compound relative to the total pool.
For bioreactor experiments, cells were trypsinized, washed in phosphate-buffered saline, and
electrostatically encapsulated at a concentrations of 25 (n = 1), 50 (n = 2), and 127 × 106 (n =
1) cells/mL in 500-μm beads, as previously described (41). Approximately 1.5 mL of
encapsulates was perfused using the same medium formulation as above, recirculated at a rate
of 4 mL/min. The bioreactor loop contains 40 mL in circulation. Medium was kept at a constant
37°C by way of water-jacketed lines, and gas pressures were maintained by a gas exchange
module using 95% air/5% CO2 gas, as previously described (42). A schematic of the bioreactor
system is shown in Fig. 1. Encapsulates were removed at the end of the experiment, embedded
in optimal cutting temperature, and stained with hematoxylin and eosin as previously described
(7) to confirm cells were greater than 90% viable.
Hyperpolarization Methods
[1-13C]-pyruvate was hyperpolarized by the DNP method (35) using the Hypersense® (Oxford
Instruments, Oxford, UK) to an average polarization of ~15%. The compound polarized was
a mixture of [1-13C]-pyruvic acid (14.2 M) and the trityl radical (15 mM; tris[8-
carboxyl-2,2,6,6-tetra[2-(1-hydroxyethyl)]-benzo(1,2-d:4,5-d)bis(1,3)dithiole-4-yl]methyl
sodium salt) (GE Health, Menlo Park, CA). Samples were dissolved in a dissolution solution
containing NaPO4 (50 mM)/ethylenediaminetetraacetic acid (EDTA) (0.3 mM) to bring the
sample to the desired concentration and average pH of 7.5. A solution of 1 mL of the
hyperpolarized pyruvate was injected into the bioreactor system with continuous flow,
resulting in a final concentration of between 2- and 14-mM pyruvate. Higher concentrations
were used in bioreactors, which contained a higher cell concentration. This was done to keep
the same relative substrate concentration throughout the group of bioreactors. The bioreactor
is water jacked and there were no observed temperature changes in the cell mass during the
studies. These concentrations were kept constant relative to the encapsulated cell concentration,
allowing the cell suspension to see an analogous influx of mass of pyruvate at each injection.
NMR Acquisition and Analysis
Cell extract samples were placed in a Speed-Vac® for 8 h to evaporate the methanol. Cell
pellets were then reconstituted in 100% deuterium oxide (D2O) (with 2.5 mM 3-(trimethylsilyl)
propionic acid (TSP) both from Sigma-Aldrich, St. Louis, MO for quantification). Media
aliquots were supplemented with 10% D2O (and a final concentration of 2.5 mM TSP). 1H and
2D 1H-1H total correlation spectroscopy spectra were acquired at 16.4 T on a Varian INOVA
(700-MHz 1H; Varian Instruments, Palo Alto, CA) equipped with 5mm 1H/13C indirect probe
at 25°C. 1H spectra of extracts were acquired using a total pulse repetition time of 12.65 sec,
number of transients of 64, and a 90° flip angle. Data were analyzed using ACD Labs 9.0 1D
NMR Processor (ACD Labs, Toronto, Ontario). 1H spectra were zero filled to 32,000 points,
line broadened 0.5 Hz using an exponential gaussian function. Peaks and 13C satellites
corresponding to glucose, lactate, alanine, glutamate, and the nucleotide spin systems of the
purines and pyrimidines (AXP+GXP, UXP+CXP) were peak fit and quantified relative to TSP
in ACD, as previously described (34,43).
2D total correlation spectroscopy (TOCSY) data were acquired with pulse repetition time =
2.48 sec, number of transients = 16, and number of indirect dimension increments of 64. Data
were linear predicted in 3 × N in the indirect dimension and zero filled to 2000 points. The data
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were 2D Fourier transformed, and cross-peaks corresponding to unlabeled and 13C-labeled
lactate, alanine, glutamate, and the ribose of nucleotides were volume integrated, as previously
described (34). These points were then used to calculate FE as the sum of the of center cross-
peaks to the total volume. The peak areas from the one-dimensional 1H and volumes from the
2D 1H-1H total correlation spectroscopy (TOCSY) were used to calculate the absolute number
of millimoles of each compound that was generated as a result of uniformly labeled 13C-glucose
metabolism.
For bioreactor studies, 13C and 31P spectra were acquired on an 11.7-T Varian INOVA (125-
MHz 13C and 202-MHz 31P; Varian Instruments) equipped with a 10mm, triple-tune, direct-
detect, broadband probe at 37°C. 31P time courses were acquired before and after
hyperpolarized injections, using a pulse repetition time = 3 sec, number of transients = 1024,
and a 90° flip angle. 31P spectra were zero filled to 40,000 points and line broadened 15 Hz.
Assessment of changes in the β-nucleotide triphosphate (βNTP) resonances as a function of
time was used to monitor cell health through the progression of the bioreactor experiments in
vivo. Hyperpolarized 13C experiments were acquired using a 5° flip angle and pulse repetition
time = 3 sec and acquired for 300 sec. Data were zero filled to 16,000 points and line broadened
5 Hz. The resonances of pyruvate (171 ppm), lactate (182 ppm) and alanine (175 ppm) were
integrated and compared as a function of time to determine the characteristics of enzymatic
interconversion as a result of pyruvate injections. Fluxes were determined using a model of
LDH and ALT labeling flux implemented in Interactive Data Language (ITT Visual
Information Solutions, Boulder, CO) normalized for injected hyperpolarized pyruvate
concentration and cell concentration estimated from relative changes in βNTP peak area.
Briefly, the pyruvate peak area over time (Mp) was modeled to determine the arrival time
(ta), rate of injection (ki), and signal decay of pyruvate (kp).
[1]
The te represents the end of the pyruvate injection time. These fitted parameters were then used
to fit the 13C lactate and alanine data to estimate LDH and ALT labeling fluxes (kpx), where
x represents either lactate or alanine (2).
[2]
One pool of pyruvate, lactate, and alanine was assumed in this model. In contrast to the model
described by Day and coworkers (9), this model includes the rate of injection, which is a result
of the flow of material into the bioreactor. This is not necessary in a model of cells in a
nonperfused system but is important when small tip angles are used to assess magnetization
as the substrate is flowing into the system. The exchange of lactate and alanine back to pyruvate
was not included in this model, and therefore we are not measuring a kinetic constant but purely
a measure of hyperpolarized label generation in time, or overall flux, which is specific for a
given cell line or tissue under a given set of conditions. The large amount of hyperpolarized
lactate observed in this study is consistent with the high LDH Keq in favor of lactate (44), as
well as in prior in vivo studies of hyperpolarized [1-13C] pyruvate (8,9,36,45).
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Extracts of 2D Cultures and Determination of the Mass Balance of Uniformly Labeled 13C-
Glucose
Figure 2a is a representative 1H spectrum of the aliphatic region obtained from a methanol
extraction of JM1 cells after metabolism of 13C-substrate for 23 h. 13C satellites of lactate,
alanine, glutamate (both as glutamate (Glut) and as the glutamyl group of the tripeptide
glutathione (GSH)), and the nucleotide riboses (not pictured) are visible. The concentrations
of these five compounds plus pyruvate and glucose in the initial medium formulation and at
23 h from the cell methanol extract and 2D culture media are given in Table 1. In comparison
to normal rat liver (46), the JM1 rat hepatoma cell line produces significantly more lactate and
alanine, and ribose (Table 1), demonstrating the Warburg effect and pentose phosphate
pathway products for nucleotide synthesis, respectively. They also demonstrate a high
concentration of glutathione, which has been observed in other cell lines such as MCF-7 human
breast cancer (47) and DU145 prostate cancer cells (48). In fact, one of the largest resonances
in the 1H spectrum is from glutathione (Fig. 2a).
Representative regions of a typical 2D 1H-1H total correlation spectroscopy spectrum are
shown in Fig. 2b, demonstrating cross-peaks used to determine the 13C FE of the previously
mentioned compounds. At 23 h, lactate and alanine FEs are 88.9 ± 2.9% and 57.8 ± 3.1%,
respectively. The glutamate and glutamyl of GSH have FEs of 7.1 ± 2.2% and 10.1 ± 2.4%,
respectively. The FEs of the ribose in nucleotides were similar for both purines and
pyrimidines, enriching to 91.6 ± 2.7 and 91.5 ± 3.8%. It is important to note that after 5 min,
the lactate pool inside the cell had an FE of 55.1 ± 7.9%, while that of alanine was 14.0 ± 5.9%.
Glutamate labeling was not detectable at 5 min. Not surprising was that lipids were not labeled
to a detectable level, likely because lipids form from anaplerotic products of the Krebs cycle.
These intermediates were at most labeled to 10%, as can be inferred from the glutamate FE,
and in turn could have internal labeled the lipids to a level below detection in this study.
By quantifying the absolute number of micromoles of 13C for each compound at 23 h in the
cell, a distribution of label can be generated, which is shown in Fig. 2c. Nearly 85% of the
label is present as either lactate or alanine in JM1 cells after 23 h. Activity of the pentose
phosphate pathway in converting glucose to the ribose backbone of nucleotides accounts for
approximately 4.7% of the 13C label distribution, while another 9.2% are resident in glutamate
(half of which is GSH). At the 23 h time point, each 150-cm2 plate of JM1 cells had produced
242.57 ± 15.79 μmol of lactate and 17.7 ± 1.53 μmol of alanine and exported it to the medium.
Bioreactor Cultures of JM1 Cells and 31P NMR Studies
31P spectra were used to monitor changes in cell energetics with growth over time. Figure 3a
shows a representative 500-μm bead of encapsulated JM1 cells, cryo-sectioned and stained by
hematoxylin and eosin at 20× magnification. JM1 cells were evenly distributed throughout the
alginate beads and were predominantly spherical. Figure 3b shows a representative 31P
spectrum of JM1 cells encapsulated to a concentration of 1.2 × 108 cells/mL at 4 h of perfusion
in the bioreactor. NMR signals for the phosphates of the NTPs (γNTP, αNTP, and βNTP),
phosphocholine, inorganic phosphate, glycerol phosphocholine,
glycerophosphoethanolamine, nicotinamide (reduced and oxidized), diphosphodiesters (most
commonly (UDP) uridine diphosphate UDP-glucose) (15,16) and the sugar phosphate groups
(sugar PO4−3) are readily visible.
Figure 4a shows a representative 31P time course of βNTP changes of JM1 cells growing in
the bioreactor over the time course of the bioreactor studies. The dotted red lines indicate the
time of injection of hyperpolarized [1-13C] pyruvate. Increases in βNTP correlate to the cell
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concentration and are indicative of the cell growth with time (13,15,21,49). About 80% of
βNTP is adenine nucleotide and about 90% is NMR visible in rat liver (50). As cells grew
inside of the bioreactor, hyperpolarized [1-13C] pyruvate was injected to assess conversion of
pyruvate to its metabolic products. Figure 4b demonstrates 31P spectra before and immediately
after two injections of hyperpolarized [1-13C] pyruvate at 4 and 18.5 h. Increases in the 31P
resonances at the later time point demonstrate that the cells not only survive the injection but
also continue to grow over time.
Previous 31P NMR studies of NMR-compatible bioreactors containing alginate-encapsulated
transformed cells (51) showed that cells are viable for several days. Here we demonstrate that
the cells double in a comparable period of time as in 2D cultures of JM1 (49). This is likely
due to the uniform diameter of 500 μm, which was permitted by use of electrostatic
encapsulation. In normal aerobic cells such as hepatocytes, the diffusion distance for oxygen
is typically 200 μm; cells become hypoxic at greater diffusion distances (38,52). Transformed
cells consume less oxygen than primary hepatocytes at 250 μm, the maximal diffusion distance
in the 500-μm diameter encapsulates. Although an oxygen gradient is created in the 500-μm-
diameter encapsulates, dictated by the diffusion coefficient and oxygen consumption rate, there
would be little or no hypoxic zone within the encapsulate compared to previous studies that
used >1mm diameter (51). In short, the relatively small and uniform diameter of the
encapsulates permitted sufficient diffusion of hyperpolarized [1-13C] pyruvate to the cells.
Bioreactor Cultures of JM1 Cells and 13C NMR DNP Studies
Figure 4c demonstrates injections of 1 mL of 7.1-mM hyperpolarized [1-13C] pyruvate at 4 h
and 18.5 h in the same bioreactor system. Each 13C spectrum is at 90 sec postinjection and
shows the high signal-to-noise ratio of labeled lactate and alanine as a result of interconversion
from the injected pyruvate. The spectrum on the right exhibits higher SNR, due to the
characteristic cell growth over time of the JM1 cells in the bioreactor. Lactate and alanine
production as a result of flux through LDH and ALT, respectively, was seen to scale with cell
concentration, as expected.
Hyperpolarized 13C spectra were integrated and time courses of lactate and alanine were
generated. Figure 5 shows the 13C spectrum of a bioreactor at 84 sec postinjection (Fig. 5a)
and its representative signal over time (Fig. 5b). The influx of pyruvate as a result of the
injection is shown, and peaks corresponding to its metabolic products, lactate and alanine, are
observed within 2 scans (i.e., 6 sec) of the pyruvate signal. A representative time course
of 13C lactate, alanine, and pyruvate is shown in Fig. 5c. This data were fit to a two-state model
of the interconversion of pyruvate to lactate and alanine, and the fit is shown as the solid line
through the raw data. The flux rates of [1-13C] pyruvate to [1-13C] lactate and [1-13C] alanine,
facilitated by LDH and ALT, were determined to be 12.18 ± 0.49 nmols/sec/108 cells and 2.39
± 0.30 nmols/sec/108 cells, respectively. The low standard error (SE) in the bioreactor supports
the reproducibility of the system as a real-time measurement of the flux through LDH. The
measurement for ALT flux exhibited a higher standard error, most likely due to the lower signal
to noise of [1-13C] alanine in hyperpolarized studies, in comparison to lactate. Figure 5d
demonstrates the differences between flux measurements that were made on the first and
second day in the bioreactor system. LDH flux and ALT flux were not found to be significantly
different between the two days (P = 0.4 and 0.6, respectively). Multiple injections of
hyperpolarized [1-13C] pyruvate were done on all bioreactors, yielding similar results, thus
reinforcing the robustness of not only the bioreactor system but also the flux measurement by
hyperpolarized [1-13C] pyruvate injection. These data suggest that differences in metabolic
fluxes with cellular perturbations (i.e., changing oxygen tension, metabolic substrates, and/or
therapy) as small as 5% can be measured in the bioreactor. Also, having accurate control over
the bead size (500 μm) of the encapsulated cells provided an environment in which all cells
Keshari et al. Page 6













are equally perfused (i.e., the 250-μm diffusion limit was maintained), a situation that is closer
to physiologic than provided by other NMR-compatible bioreactors (19,38,49,51).
The pyruvate metabolism in the bioreactor system, assessed by the DNP method, demonstrated
fluxes through LDH and ALT analogous to those of glucose in the standard 2D culture system.
Unlike the first cell study showing flux through LDH by DNP (9), concentrations in this study
(Table 1) were closer to the physiologic conditions, as a result of continuous perfusion. The
bolus of pyruvate creates a spike in pyruvate concentration that is similar for both perfused
bioreactor and in vivo magnetic resonance spectroscopic imaging (MRSI) studies (1).
Typically, the serum concentrations for these compounds are in the half to several millimolar
range, and medium is near this range, except for glucose, which is several fold higher (25 mM
[4.5g/L] vs 3.9 to 6.1 mM [0.7–1.1 g/L]) (52), as well as pyruvate, which is very low in serum
(500 μM vs 100 μM). The goal of this study was to generate a model similar to an animal model.
Although in both bioreactor and in vivo DNP studies a nonphysiologic bolus of pyruvate is
given, a similar dose can be given in both cases for comparison of the ex vivo and in vivo
fluxes. This information can be used in order to rapidly test novel molecules and save time,
money, and animal lives for development of DNP imaging.
Metabolic fluxes, even for kinetically fast enzymes such as LDH, can be measured while
maintaining cells in a physiologically viable state. This also allows for the monitoring of
enzyme concentration, as well as real-time metabolism by way of modulation of substrate
concentration. Combining 13C labeling interleaved between hyperpolarized 13C studies would
allow for the assessment of both kinetically fast and slow metabolic processes. It must be noted
that hyperpolarized 13C studies may not be appropriate for measuring slower metabolic fluxes
or sequential steps in an enzymatic pathway (i.e., flux to glutamate or fatty acids). However,
the dramatic increase in sensitivity provided by DNP will potentially allow for the measurement
of fast metabolic fluxes in people.
Summary
This study demonstrates that hyperpolarized 13C NMR can be combined with an NMR-
compatible bioreactor to measure metabolic fluxes in three-dimensional cell cultures. JM1
hepatoma cells were found to have a high rate of aerobic glycolysis in both conventional 2D
culture and in the bioreactor. The high sensitivity of hyperpolarized 13C NMR allowed the
measurement of metabolic fluxes in real time. Although this preliminary study involved
immortalized cells, this combination of technologies could be extended to the real-time
metabolic exploration of primary benign and cancerous cells and tissues.
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Schematic of bioreactor setup. The red line indicates the flow of media as it recirculates in the
bioreactor. GEM, gas exchange module.
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a: Representative 1H spectrum of water soluble metabolites at 23 h. b: Representative total
correlation spectroscopy spectra showing FE of compounds by infusion of uniformly
labeled 13C-glucose. c: Cancer metabolic phenotype. Percentages ± standard of deviation are
shown for the distribution of 13C compounds in the cell as a result of medium supplemented
with uniformly labeled 13C glucose. The DNP pyruvate arrow denotes the mechanism for
infusion of hyperpolarized pyruvate and its relationship to the distributions measured in 2D
cultures of JM1 cells. Yellow box: glucose transporter (GLUT) (1,3,4); blue box: MCT:
monocarboxylate transporter (predominantly 4). Light blue: pentose phosphate pathway (PPP)
flux into ribose etc. Pink box: anaerobic/aerobic glycolysis. Light yellow box: tricarboxylic
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acid cycle (TCA). Aqua box: urea cycle. Light red box: fatty acid synthesis as a result of
exchange with TCA pathway. Light green box: flux through ALT and into protein synthesis.
*Indication of methodology of hyperpolarized pyruvate. **In lipid extracts, carbon labeling
was below detection.
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Representative 31P and histology of encapsulated beads. a: Hematoxylin and eosin–stained
section of a 500-μm bead of encapsulated JM1 cells at 20× magnification. b:
representative 31P spectrum at 4 h postencapsulation and perfusion in the bioreactor. γNTP,
αNTP, and βNTP represent the phosphates of the NTPs. PC, phosphocholine; Pi, inorganic
phosphate (this peak is composed of the Pi inside and outside the cell); GPC,
glycerolphosphocholine; GPE, glycerophosphoethanolamine; NAD(H), nicotinamide
(reduced and oxidized); DPDE, diphosphodiesters, most commonly UDP glucose; sugar
PO4, sugar phosphate groups.
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31P monitoring and dynamic 13C spectra of JM1 cells. a: A 31P time course showing the relative
changes in βNTP as JM1 cells encapsulated at a concentration of 127 × 106 cells/mL change
over time. b: Before and after 31P spectra at the dictated time points of injection of 1 mL of
7.1-mM hyperpolarized pyruvate, 4 h and 18.5 h, respectively. c: 13C spectra at 90 sec
postinjection, demonstrating the conversion of pyruvate (171 ppm) to lactate (182 ppm) and
alanine (175 ppm).
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Study in bioreactor of JM1 cells at a concentration of 50 × 106 cells/mL. a: 13C spectrum
acquired at 84 sec postinjection of 2 mL of 3.56-mM hyperpolarized pyruvate. b: Every
third 13C spectrum acquired demonstrating the hyperpolarized 13C labeling of lactate (Lac)
and alanine (Ala) as result of 13C pyruvate (Pyr). Pyruvate hydrate (Pyr-H) is also shown,
which is in equilibrium with pyruvate. c: Red dots, pyruvate; blue dots, lactate ×10; green dots,
alanine ×10; the lines for each respective color are the fits as a result of the flux model
for 13C labeling of lactate and alanine via LDH and ALT, respectively. d: LDH (blue) and
ALT (red) flux measurements for days 1 and 2 in the bioreactors.
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Table 1
Glucose, Pyruvate, Glutamate, Glutamine, Alanine, Lactate, X-Purine, X-Pyrimidine, and Glutathione




2D cultures (methanol) (μmols/
106 cells) 2D cultures (media) (μmol)
Glucose 249 — 111.84 ± 7.61
Pyruvate 15 — —
Glutamate 0 0.037 ± 0.002 —
Glutamine 60 — 53.95 ± 0.63
Glutathione 0 0.046 ± 0.004 —
Alanine 0 0.026 ± 0.003 17.07 ± 1.53
Lactate 0 0.091 ± 0.007 242.57 ± 15.79
X-Purine 0 0.002 ± 0.0004 —
X-Pyrimidine 0 0.002 ± 0.0005 —
— Indicates compounds that were not detected by NMR.
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